Free Trial

Privia Health Group (PRVA) Stock Price, News & Analysis

Privia Health Group logo
$20.47 -0.63 (-2.99%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$20.46 0.00 (-0.02%)
As of 07/11/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Privia Health Group Stock (NASDAQ:PRVA)

Key Stats

Today's Range
$20.41
$21.20
50-Day Range
$20.47
$25.07
52-Week Range
$16.47
$26.09
Volume
907,718 shs
Average Volume
768,313 shs
Market Capitalization
$2.50 billion
P/E Ratio
170.60
Dividend Yield
N/A
Price Target
$28.38
Consensus Rating
Buy

Company Overview

Privia Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
90th Percentile Overall Score

PRVA MarketRank™: 

Privia Health Group scored higher than 90% of companies evaluated by MarketBeat, and ranked 111th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Privia Health Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Privia Health Group has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Privia Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Privia Health Group are expected to grow by 92.86% in the coming year, from $0.14 to $0.27 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Privia Health Group is 170.60, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.84.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Privia Health Group is 170.60, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.13.

  • Price to Earnings Growth Ratio

    Privia Health Group has a PEG Ratio of 3.38. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Privia Health Group has a P/B Ratio of 3.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Privia Health Group's valuation and earnings.
  • Percentage of Shares Shorted

    3.03% of the float of Privia Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Privia Health Group has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Privia Health Group has recently decreased by 4.66%, indicating that investor sentiment is improving.
  • Dividend Yield

    Privia Health Group does not currently pay a dividend.

  • Dividend Growth

    Privia Health Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.03% of the float of Privia Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Privia Health Group has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Privia Health Group has recently decreased by 4.66%, indicating that investor sentiment is improving.
  • News Sentiment

    Privia Health Group has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Privia Health Group this week, compared to 4 articles on an average week.
  • Search Interest

    4 people have searched for PRVA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,100,368.00 in company stock.

  • Percentage Held by Insiders

    10.70% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Privia Health Group's insider trading history.
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

PRVA Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
PRVA Privia Health Group, Inc. - Seeking Alpha
Privia Health Group Inc (PRVA) - Investing.com
See More Headlines

PRVA Stock Analysis - Frequently Asked Questions

Privia Health Group's stock was trading at $19.55 at the start of the year. Since then, PRVA stock has increased by 4.7% and is now trading at $20.47.

Privia Health Group, Inc. (NASDAQ:PRVA) released its quarterly earnings data on Thursday, August, 8th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.02. The firm's revenue was up 2.2% compared to the same quarter last year.
Read the conference call transcript
.

Privia Health Group (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Top institutional investors of Privia Health Group include Harbor Capital Advisors Inc. (0.03%), Trust Point Inc. (0.02%), Financiere des Professionnels Fonds d investissement inc. (0.01%) and Financiere des Professionnels Fonds d investissement inc. (0.01%). Insiders that own company stock include Adam Boehler, William M Sullivan, Jeffrey B Butler, Parth Mehrotra, David Mountcastle, Advisors LLC Mbd, Thomas Bartrum, Matthew Shawn Morris and Thomas A Mccarthy.
View institutional ownership trends
.

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Privia Health Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
8/08/2024
Today
7/12/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PRVA
CIK
1759655
Fax
N/A
Employees
1,140
Year Founded
N/A

Price Target and Rating

High Price Target
$40.00
Low Price Target
$23.00
Potential Upside/Downside
+38.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.12
Trailing P/E Ratio
170.60
Forward P/E Ratio
146.21
P/E Growth
3.38
Net Income
$14.39 million
Net Margins
0.87%
Pretax Margin
1.79%
Return on Equity
2.32%
Return on Assets
1.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.88
Quick Ratio
1.88

Sales & Book Value

Annual Sales
$1.74 billion
Price / Sales
1.44
Cash Flow
$0.18 per share
Price / Cash Flow
116.94
Book Value
$5.70 per share
Price / Book
3.59

Miscellaneous

Outstanding Shares
121,920,000
Free Float
108,875,000
Market Cap
$2.50 billion
Optionable
Optionable
Beta
0.82
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:PRVA) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners